ALERT: A cyber incident at Optum/Change Healthcare may delay Luminis Health bill processing. Watch for fraud and verify any concerning messages with your provider's office. We are working to minimize disruptions.
Title of the Project
A 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores
Service Line not in Drupal
Surgery
Format of the Project
Journal Article
Affiliated Specialties not in Drupal
Breast
Name of Publication
Breast Cancer Research and Treatment